The result of RNA pull‐down assay suggested that FTX interacted with miR‐200a‐3p in lung cancer cells, and Luciferase Reporter Gene Assay indicated that miR‐200a‐3p could both target FTX and FOXA2 genes. The gene discussed is FOXA2; the disease is lung cancer.